News

2024/08/07 Press Release

The results of a study on the usefulness of sublingual vaccines in influenza made the cover of the scientific journal Vaccines.

2024/03/04 Press Release

Biotube Co., Ltd. became the subsidiary of EPS Innovative Medicine (Japan) Co., Ltd.

2023/12/22 Press Release

The enrolment of patients has been initiated in the investigator-initiated clinical trials to which FEF Pharmaceutical Co., Ltd. provides investigational drugs

2023/12/21 Press Release

Be selected as a FINALIST at 2023 JINJI LAKE Innovation & Entrepreneurship Competition

2023/11/15 Press Release

Patients with allergic rhinitis and allergic to cedar pollinosis have lower saliva-secretory IgA than healthy subjects

2023/09/29 Press Release

Concluded a jointresearch agreementwith C-HAS+ Co., Ltd. for xploring useful substances for anti-obesity contained in natural products

2023/09/25 Press Release

Having prospect for the development of simple, highly effective and safe sublingual vaccines

2023/06/16 Press Release

Joint R&D Agreement for Regenerative Medicine Using Brown Adipocytes (for Slimming/weight loss)Concluded with Medical Corporation Tomoshibikai FIRE CLINIC

2023/04/01 News

Notice of Change of Representative Director

2023/02/21 News

FEF Pharmaceutical Co., Ltd. and Kyoto University have initiated a collaborative research project aimed at developing a novel treatment for lower extremity artery disease (LEAD).